文献速递冠心病外科

糖尿病患者非体外与体外冠状动脉旁路移植的远期结局:台湾全国性研究

Late outcomes of off-pump versus on-pump coronary bypass in patients with diabetes: A nationwide study from Taiwan.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-09-27

该研究比较糖尿病患者接受非体外与体外冠状动脉旁路移植的远期结局,纳入2000至2011年16215例单纯搭桥患者,采用倾向性评分匹配分析。非体外组远期再次血运重建更多,但两组远期死亡、卒中和心肌梗死风险无显著差异;非体外组30天生存获益,合并终末期肾病患者体外循环有远期生存优势。

要点

  • 糖尿病患者非体外搭桥远期再次血运重建风险更高(P = .0036)。
  • 两组远期死亡、卒中、心肌梗死风险无显著差异。
  • 合并终末期肾病患者体外循环搭桥有远期生存获益。

核心结论

  • 糖尿病患者非体外搭桥有30天生存获益,但远期生存与体外搭桥相似。
  • 非体外搭桥远期再次血运重建是需关注的问题。
  • 合并终末期肾病的糖尿病患者体外搭桥有远期生存获益。

研究设计与样本

  • 研究纳入2000至2011年16215例接受单纯冠状动脉旁路移植的糖尿病患者。
  • 采用倾向性评分匹配分析比较远期结局,匹配后每组3796例。

主要发现

  • 非体外搭桥与远期再次血运重建发生率更高相关(P = .0036)。
  • 两组远期死亡风险无显著差异(HR 0.95;95%CI 0.87-1.02,P = .1667)。
  • 两组远期卒中风险无显著差异(HR 0.97;95%CI 0.87-1.09,P = .6074)。
  • 两组远期心肌梗死风险无显著差异(HR 1.05;95%CI 0.91-1.20,P = .5207)。
  • 非体外搭桥有30天生存获益(HR on vs off 1.52,95%CI 1.24-1.85,P < .0001)。

关键数值与推荐

  • 合并终末期肾病患者体外搭桥有远期生存获益(HR on vs off 0.68,95%CI 0.51-0.91)。

临床怎么用

  • 糖尿病患者选择搭桥策略时需权衡非体外30天生存获益与远期再次血运重建风险。
  • 合并终末期肾病的糖尿病患者可优先考虑体外循环搭桥以获取远期生存获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although the benefits and risks of on- and off-pump coronary artery bypass have been compared in several clinical trials, large-scale studies regarding long-term outcomes in patients with diabetes are lacking. We compared long-term outcomes after on- and off-pump coronary artery bypass in patients with diabetes. METHODS: We evaluated outcomes in 16,215 patients with diabetes who underwent isolated coronary artery bypass from 2000 to 2011. Clinical data validity was regulated by the single-payer, universal, and nationwide reimbursement systems. Long-term outcomes were compared using propensity score matched analyses. RESULTS: Off-pump surgery was associated with a greater incidence of repeat revascularization (P = .0036) in the long term. Propensity score matching identified 3796 patients in each group. There were no significant differences between on- and off-pump surgery regarding the long-term risks of mortality (hazard ratio [HR], 0.95; 95% confidence interval [CI], 0.87-1.02, P = .1667), stroke (HR, 0.97; 95% CI, 0.87-1.09, P = .6074), and myocardial infarction (HR, 1.05; 95% CI, 0.91-1.20, P = .5207). Off-pump surgery offered a survival benefit within 30 days (HR on vs off, 1.52, 95% CI, 1.24-1.85, P < .0001). In patients with diabetes and end-stage renal disease, on-pump surgery provided a significant long-term survival benefit (HR on vs off, 0.68, 95% CI, 0.51-0.91). CONCLUSIONS: In patients with diabetes undergoing isolated coronary artery bypass, off-pump surgery provided a 30-day benefit in mortality, but both groups had similar long-term survival. In off-pump surgery, repeat revascularization was a concern in the long term. In patients with diabetes and end-stage renal disease, on-pump surgery has long-term survival benefits.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Huang KC, Wu IH, Chou NK, et al. Late outcomes of off-pump versus on-pump coronary bypass in patients with diabetes: A nationwide study from Taiwan. J Thorac Cardiovasc Surg. 2018. PMID: 30482526. doi:10.1016/j.jtcvs.2018.08.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。